Santen Pharmaceutical Co., Ltd. has contributed to the protection and improvement of people's eyesight and health. Santen's integrated operations extend from research and development to production and sales of prescription and over-the-counter pharmaceuticals.

Today, Santen specializes in original ophthalmic and anti-rheumatic pharmaceuticals as it works to create superior pharmaceuticals for all types of ophthalmic disorders and offer information that meets clinical needs. As a result, Santen leads Japan's market for prescription ophthalmics, which represent over 80 percent of Company sales. With marketing and development bases in Japan, the United States and Europe, backed by first-rate R&D capabilities, Santen aims to increase corporate value to become a world-class company that delivers unique products to patients worldwide.